These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26941998)

  • 1. Conjunctival Lymphangiogenesis Was Associated with the Degree of Aggression in Substantial Recurrent Pterygia.
    Zhao W; Wang T; Deng J; Zhong L; Huang W; Ling S
    J Ophthalmol; 2016; 2016():1592514. PubMed ID: 26941998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations between lymphangiogenesis and the size of pterygium.
    Liu L; Ling SQ; Li QL; Wang T; Ye H; Yang JZ; Jia XH
    Int J Ophthalmol; 2012; 5(3):312-6. PubMed ID: 22773979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.
    Ling S; Li Q; Lin H; Li W; Wang T; Ye H; Yang J; Jia X; Sun Y
    Eye (Lond); 2012 Nov; 26(11):1451-8. PubMed ID: 22975656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between angiogenesis and lymphangiogenesis in recurrent pterygium.
    Qi CX; Zhang XD; Yuan J; Yang JZ; Sun Y; Wang T; Ye H; Ling SQ
    Int J Ophthalmol; 2012; 5(6):655-60. PubMed ID: 23275896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing lymphatic microvessel density in primary pterygia.
    Ling S; Liang L; Lin H; Li W; Xu J
    Arch Ophthalmol; 2012 Jun; 130(6):735-42. PubMed ID: 22801834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic microvessel density as a predictive marker for the recurrence time of pterygium: a three-year follow-up study.
    Lin H; Luo L; Ling S; Chen W; Liu Z; Zhong X; Wu C; Chen W; Liu Y
    Mol Vis; 2013; 19():166-73. PubMed ID: 23378730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution.
    Martín-López J; Pérez-Rico C; García-Honduvilla N; Buján J; Pascual G
    Histol Histopathol; 2019 Aug; 34(8):917-929. PubMed ID: 30821336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctival autograft for pterygium.
    Clearfield E; Muthappan V; Wang X; Kuo IC
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD011349. PubMed ID: 26867004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians.
    Wong VA; Law FC
    Ophthalmology; 1999 Aug; 106(8):1512-5. PubMed ID: 10442896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative activity and p53 expression in primary and recurrent pterygia.
    Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
    Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival Autofluorescence and Cytological Changes in Pterygium.
    S Pai SV; Kishore A; Sen S; Sharma N; Tandon R
    Cornea; 2022 May; 41(5):583-586. PubMed ID: 34469339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft.
    Kheirkhah A; Hashemi H; Adelpour M; Nikdel M; Rajabi MB; Behrouz MJ
    Ophthalmology; 2012 Feb; 119(2):227-32. PubMed ID: 22153864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium.
    Al Fayez MF
    Ophthalmology; 2002 Sep; 109(9):1752-5. PubMed ID: 12208727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Peroxiredoxin 2 and Vascular Endothelial Growth Factor Receptor 2 in Pterygium.
    Wang Y; Lin J; Chen L; Wang L; Hao P; Han R; Ying M; Li X
    Cornea; 2017 Jul; 36(7):841-844. PubMed ID: 28489720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amniotic membrane transplantation with narrow-strip conjunctival autograft vs conjunctival autograft for recurrent pterygia.
    Barbosa JB; De Farias CC; Hirai FE; Pereira Gomes JÁ
    Eur J Ophthalmol; 2017 Mar; 27(2):135-140. PubMed ID: 27405284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p63 and p16 in primary and recurrent pterygia.
    Ramalho FS; Maestri C; Ramalho LN; Ribeiro-Silva A; Romão E
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1310-4. PubMed ID: 16523297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
    Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
    Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor lymphangiogenesis in cervical squamous cell carcinoma and its clinical significance].
    Zhang JP; Lü WG; Chen HZ; Zhou CY; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1551-4. PubMed ID: 16179117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells.
    Dushku N; John MK; Schultz GS; Reid TW
    Arch Ophthalmol; 2001 May; 119(5):695-706. PubMed ID: 11346397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphB4 expression in pterygium is associated with microvessel density.
    Xue C; Chen Y; Huang Z; Ge Y; Wang H; Wang J
    Int J Clin Exp Med; 2014; 7(11):4008-15. PubMed ID: 25550909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.